Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Enliven Therapeutics
Enliven Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Enliven Therapeutics
Stock Price
$28.5
2024-10-29
Market Capitalization
$1.3 B
2024-10-29
Enliven Therapeutics Summary
Company Summary
Overview
Enliven Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on discovering and developing small-molecule kinase inhibitor therapies to treat cancer.
Type
Public
Status
Active
Founded
2019
Website
https://www.enliventherapeutics.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
oncology
therapy
Homepage
Linkedin
twitter
Table of Contents
Competitors
Competitors and Similar Companies
CARsgen Therapeutics
Healthcare - Private
Day One Biopharmaceuticals
Healthcare - Public
Artiva Biotherapeutics
Healthcare - Public
Iksuda Therapeutics
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top